<DOC>
	<DOCNO>NCT01264549</DOCNO>
	<brief_summary>Development stroke associate pneumonia ( SAP ) detrimental effect stroke outcome . Biomarker-guided antibiotic treatment patient high risk pneumonia may help improve stroke outcome . Therefore , investigator evaluate whether intensified infection monitoring via Procalcitonin guide early standardize antibiotic treatment improve functional outcome stroke compare standard therapy base current guideline .</brief_summary>
	<brief_title>Stroke Adverse Outcome Associated With Nosocomial Infections : PCTus- Guided Antibacterial Therapy Severe Ischemic Stroke Patients ( STRAWINSKI )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>age ≥18 year stroke onset within last 40 hour randomisation clinical diagnosis severe ( NIHSS &gt; 9 ) , nonlacunar stroke middle cerebral artery territory consent give patient his/her legitimate representative patient incapable give consent CT evidence intracerebral haemorrhage lacunar infarct probable cause current illness Antibiotic use within last 10 day Suspected life expectancy &lt; 3 month Participation interventional trial ( pharmaceutical medical device ) Pregnancy , lactation Prestroke mRS score ≥ 4</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>stroke-associated infection</keyword>
	<keyword>biomarkers</keyword>
	<keyword>PCT</keyword>
	<keyword>immune infection parameter</keyword>
</DOC>